Amniotic membrane extract differentially regulates human peripheral blood T cell subsets, monocyte subpopulations and myeloid dendritic cells

Cell Tissue Res. 2018 Aug;373(2):459-476. doi: 10.1007/s00441-018-2822-1. Epub 2018 Mar 26.

Abstract

The discovery of the immunoregulatory potential of human amniotic membrane (hAM) propelled several studies focusing on its application for the treatment of immunological disorders. However, there is little information regarding the effects of hAM on distinct activation and differentiation stages of immune cells. Here, we aim to investigate the effect of human amniotic membrane extract (hAME) on the pattern of cytokine production by T cells, monocytes and myeloid dendritic cells (mDCs). For this purpose, peripheral blood mononuclear cells (PBMCs) from eight healthy individuals were stimulated in vitro in the presence or absence of hAME. Mitogen-induced proliferation of PBMCs and cytokine production among the distinct T cell functional compartments, monocyte subpopulations and mDCs were evaluated. hAME displayed an anti-proliferative effect and decreased the frequency of T cells producing tumor necrosis factor (TNF)α, interferon (IFN)γ and interleukin (IL)-2, for all T cell functional compartments. The frequency of IL-17 and IL-9-producing T cells was also reduced. The inhibition of mRNA expression of granzyme B, perforin and NKG2D by CD8+ T cells and γδ T cells and the augment of FoxP3 and IL-10 in CD4+ T cells and IL-10 in regulatory T cells were also observed. Furthermore, hAME inhibited IFNγ-induced protein (IP)-10 expression by classical and non-classical monocytes, without hampering the production of TNFα and IL-6 by monocytes and mDCs. These results suggest that hAME exerts an anti-inflammatory effect on T cells, still at a different extent for distinct T cell functional compartments.

Keywords: Dendritic cell; Human amniotic membrane; Immunosuppression; Monocyte; T cell.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amnion / metabolism*
  • Cell Proliferation / drug effects
  • Dendritic Cells / cytology*
  • Dendritic Cells / drug effects
  • Female
  • Humans
  • Interferon-gamma / metabolism
  • Interleukin-17 / metabolism
  • Interleukin-2 / metabolism
  • Interleukin-9 / metabolism
  • Lymphocyte Count
  • Male
  • Middle Aged
  • Mitogens / pharmacology
  • Monocytes / cytology*
  • Monocytes / drug effects
  • Myeloid Cells / cytology*
  • Myeloid Cells / drug effects
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • T-Lymphocyte Subsets / cytology*
  • T-Lymphocyte Subsets / drug effects
  • Transcription, Genetic / drug effects
  • Tumor Necrosis Factor-alpha / metabolism
  • Young Adult

Substances

  • IL17A protein, human
  • Interleukin-17
  • Interleukin-2
  • Interleukin-9
  • Mitogens
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Interferon-gamma